Randal W. Scott, Director at Talis Biomedical Corp (TLIS), bought 20,000 shares at $10.16 ($203K) on 2021-05-14, disclosed to the SEC on 2021-05-18.
Open-market purchase of $203k TLIS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.16 | 9,000 | $91K | 45.1% |
| 2 | $10.11 | 11,000 | $111K | 54.9% |
| Total | $10.13 avg | 20,000 | $203K | 100% |
| Filing → |
| BBIO | SELL | 2025-11-19 | $1.3M | — | Filing → |
| BBIO | SELL | 2024-06-05 | $76K | — | Filing → |
| BBIO | SELL | 2024-03-05 | $85K | — | Filing → |